Carcinoma, Squamous Cell  >>  Mekinist (trametinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mekinist (trametinib) / Novartis, BeiGene
NCT01553851: GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer

Completed
2
20
US
GSK1120212, Trametinib, Mekinist
Washington University School of Medicine, National Comprehensive Cancer Network
Neoplasms, Oral, Mouth Neoplasms
06/15
12/15

Download Options